Related Experiment Videos
One hundred patients' experience with the Jyros valve
R K Walesby1, C Di Salvo, M M Black
1Department of Cardiothoracic Surgery, London Chest Hospital, UK.
The Journal of Cardiovascular Surgery
|December 1, 1996
Summary
The innovative Jyros mechanical heart valve, designed to prevent blood clots, shows excellent in-vivo performance. This space-technology derived valve achieved its theoretical potential in a large patient study.
Area of Science:
- Cardiovascular Surgery
- Biomedical Engineering
- Materials Science
Background:
- The development of mechanical heart valves aims to eliminate blood stagnation and reduce thromboembolic events.
- The Jyros valve utilizes pyrolytic carbon leaflets with rotational capability, inspired by Russian space research technology.
Observation:
- In vivo assessment of 107 Jyros mechanical heart valves in 100 patients (age 33-80) at London Chest Hospital since 1992.
- Patient cohort included re-replacements for xenografts and those undergoing concomitant revascularization.
- Valve rotation, visualized via echocardiography and X-ray screening, was observed to be continuous, intermittent, or absent in different patients.
Findings:
- No late thromboembolic events were recorded in the study population.
- Two patients experienced strokes post-procedure (AVR & CABG), and two valves were explanted due to endocarditis.
- No excessive hemolysis or mechanical valve-related failures were observed, with performance matching theoretical potential.
Implications:
- The Jyros valve demonstrates promising clinical outcomes, potentially offering an improved solution for heart valve replacement.
- The rotational design may contribute to reduced thromboembolic risk, warranting further investigation.
- This study represents the largest single-user experience with the Jyros mechanical heart valve to date.